NovaBay Pharmaceuticals Inc (NBY)

[Tkrtape]

Be advised: on April 9th a successful
Phase 3 was completed by Shire on a
Dry eye/blephoritis drug called Lifitegrast.
It has been given priority review by the FDA
And the decision date is set for Oct.25.for
It's potential approval.
Analysts also estimate half a billion on this drug
Just like NBY predicts... So a new
Competitor is potentially coming.
This drug is in eye drop form. 2x daily.
If it's covered by insurance, that will be a problem
For NBY. Granted, NBY states that the $30-$40
Is equivalent to a co-pay, but I'm not not paying
Any copay for drugs right now because I hit my deductible and my
Drugs are free for the rest of the year.